These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

304 related items for PubMed ID: 18328983

  • 1. Osteogenesis imperfecta.
    Glorieux FH.
    Best Pract Res Clin Rheumatol; 2008 Mar; 22(1):85-100. PubMed ID: 18328983
    [Abstract] [Full Text] [Related]

  • 2. [Genetic basis for skeletal disease. Osteogenesis imperfecta].
    Tanaka H.
    Clin Calcium; 2010 Aug; 20(8):1245-52. PubMed ID: 20675936
    [Abstract] [Full Text] [Related]

  • 3. Osteogenesis imperfecta.
    Huber MA.
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Mar; 103(3):314-20. PubMed ID: 17223585
    [Abstract] [Full Text] [Related]

  • 4. [Hearing is not affected by diphosphonates in osteogenesis imperfecta. Retrospective study of 42 medical records].
    Brodd I, Hederstierna C, Sääf M, Hultcrantz M.
    Lakartidningen; 2007 Mar; 108(39):1906-9. PubMed ID: 22111228
    [No Abstract] [Full Text] [Related]

  • 5. Experience with bisphosphonates in osteogenesis imperfecta.
    Glorieux FH.
    Pediatrics; 2007 Mar; 119 Suppl 2():S163-5. PubMed ID: 17332237
    [Abstract] [Full Text] [Related]

  • 6. Low-dose intravenous pamidronate treatment in osteogenesis imperfecta.
    Gökşen D, Coker M, Darcan S, Köse T, Kara S.
    Turk J Pediatr; 2006 Mar; 48(2):124-9. PubMed ID: 16848111
    [Abstract] [Full Text] [Related]

  • 7. [Osteogenesis imperfecta].
    Forin V.
    Presse Med; 2007 Dec; 36(12 Pt 2):1787-93. PubMed ID: 17560761
    [Abstract] [Full Text] [Related]

  • 8. Osteogenesis imperfecta: questions and answers.
    Shapiro JR, Sponsellor PD.
    Curr Opin Pediatr; 2009 Dec; 21(6):709-16. PubMed ID: 19907330
    [Abstract] [Full Text] [Related]

  • 9. Decrease of serum alkaline phosphatase after three cycles of pamidronate disodium in children with severe osteogenesis imperfecta.
    Cabral de Menezes Filho H, Rodrigues JM, Radonsky V, Della Manna T, Kuperman H, Steinmetz L, Dichtchekenian V, Damiani D, Setian N.
    Horm Res; 2007 Dec; 68 Suppl 5():207-8. PubMed ID: 18174750
    [No Abstract] [Full Text] [Related]

  • 10. Treatment of osteogenesis imperfecta: who, why, what?
    Glorieux FH.
    Horm Res; 2007 Dec; 68 Suppl 5():8-11. PubMed ID: 18174695
    [Abstract] [Full Text] [Related]

  • 11. Reduction of plasma taurine level in children affected by osteogenesis imperfecta during bisphosphonate therapy.
    D'Eufemia P, Finocchiaro R, Zambrano A, Tetti M, Ferrucci V, Celli M.
    Biomed Pharmacother; 2007 May; 61(4):235-40. PubMed ID: 17275249
    [Abstract] [Full Text] [Related]

  • 12. Update on the evaluation and treatment of osteogenesis imperfecta.
    Harrington J, Sochett E, Howard A.
    Pediatr Clin North Am; 2014 Dec; 61(6):1243-57. PubMed ID: 25439022
    [Abstract] [Full Text] [Related]

  • 13. Cyclic intravenous pamidronate in a very low-birthweight infant with osteogenesis imperfecta.
    Eto S, Hada S, Fukuhara R, Nishimura G, Takagi M.
    Pediatr Int; 2018 May; 60(5):485-486. PubMed ID: 29700899
    [No Abstract] [Full Text] [Related]

  • 14. Effect of intravenous pamidronate therapy on everyday activities in children with osteogenesis imperfecta.
    Löwing K, Aström E, Oscarsson KA, Söderhäll S, Eliasson AC.
    Acta Paediatr; 2007 Aug; 96(8):1180-3. PubMed ID: 17578486
    [Abstract] [Full Text] [Related]

  • 15. [Osteogenesis imperfecta].
    Schuh A, Hönle W, Effenberger H.
    MMW Fortschr Med; 2009 Nov 26; 151(48):38, 40. PubMed ID: 20085061
    [No Abstract] [Full Text] [Related]

  • 16. Effects of bisphosphonates on tooth eruption in children with osteogenesis imperfecta.
    Kamoun-Goldrat A, Ginisty D, Le Merrer M.
    Eur J Oral Sci; 2008 Jun 26; 116(3):195-8. PubMed ID: 18471236
    [Abstract] [Full Text] [Related]

  • 17. Osteogenesis imperfecta.
    Rauch F, Glorieux FH.
    Lancet; 2004 Apr 24; 363(9418):1377-85. PubMed ID: 15110498
    [Abstract] [Full Text] [Related]

  • 18. Brainstem and cerebellar hypoplasia associated with osteogenesis imperfecta type-5.
    Syamlal S, Shine S, Kunju M.
    J Postgrad Med; 2006 Apr 24; 52(2):152-3. PubMed ID: 16679688
    [No Abstract] [Full Text] [Related]

  • 19. [Treatment of osteogenesis imperfecta with bisphosphonates].
    Tau C.
    Medicina (B Aires); 2007 Apr 24; 67(4):389-95. PubMed ID: 17891938
    [Abstract] [Full Text] [Related]

  • 20. Two doses of pamidronate in infants with osteogenesis imperfecta.
    Senthilnathan S, Walker E, Bishop NJ.
    Arch Dis Child; 2008 May 24; 93(5):398-400. PubMed ID: 18089634
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.